Prot #BA3011-001: A Phase 1/2 Dose Escalation and Dose Expansion Study of BA3011 Alone and in Combination with Nivolumab in Adult and Adolescent Patients 12 Years and Older with Advanced Solid Tumors

Project: Research project

Project Details

StatusActive
Effective start/end date10/29/21 → 10/29/24

Funding

  • Covance Inc. ((OE) Prot #BA3011-001 // (OE) Prot #BA3011-001)
  • BioAtla, Inc ((OE) Prot #BA3011-001 // (OE) Prot #BA3011-001)